Epidarex Capital Successfully Raises Fund to Make Significant Investments in Early-stage UK Life Sciences
May 29, 2014
Epidarex Capital, a leading international venture capital firm, has raised over £47.5 million to lead investments in early-stage life science and health technology companies, including